PTPRC and T-cell non-Hodgkin lymphoma: Analyses of the lymphocytic markers CD3 (DAKO) and B220 (BD Pharmingen) by immunohistochemistry (IHC) demonstrated that all thetumors were positive only for CD3, indicating that the cancers were T-cell lymphomas (Figure 2A).